These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31611695)

  • 21. Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis.
    Bordbar A; Bagheri KP; Ebrahimi S; Parvizi P
    Infect Genet Evol; 2020 Jun; 80():104189. PubMed ID: 31931259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.
    Lee MN; Meyerson M
    Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep convolutional neural networks for pan-specific peptide-MHC class I binding prediction.
    Han Y; Kim D
    BMC Bioinformatics; 2017 Dec; 18(1):585. PubMed ID: 29281985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets.
    Shao XM; Bhattacharya R; Huang J; Sivakumar IKA; Tokheim C; Zheng L; Hirsch D; Kaminow B; Omdahl A; Bonsack M; Riemer AB; Velculescu VE; Anagnostou V; Pagel KA; Karchin R
    Cancer Immunol Res; 2020 Mar; 8(3):396-408. PubMed ID: 31871119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.
    Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M
    J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INeo-Epp: A Novel T-Cell HLA Class-I Immunogenicity or Neoantigenic Epitope Prediction Method Based on Sequence-Related Amino Acid Features.
    Wang G; Wan H; Jian X; Li Y; Ouyang J; Tan X; Zhao Y; Lin Y; Xie L
    Biomed Res Int; 2020; 2020():5798356. PubMed ID: 32626747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
    Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
    Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APEX-pHLA: A novel method for accurate prediction of the binding between exogenous short peptides and HLA class I molecules.
    Su Z; Wu Y; Cao K; Du J; Cao L; Wu Z; Wu X; Wang X; Song Y; Wang X; Duan H
    Methods; 2024 Aug; 228():38-47. PubMed ID: 38772499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy.
    Berlin C; Kowalewski DJ; Schuster H; Mirza N; Walz S; Handel M; Schmid-Horch B; Salih HR; Kanz L; Rammensee HG; Stevanović S; Stickel JS
    Leukemia; 2015 Mar; 29(3):647-59. PubMed ID: 25092142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus classification of human leukocyte antigen class II proteins.
    Saha I; Mazzocco G; Plewczynski D
    Immunogenetics; 2013 Feb; 65(2):97-105. PubMed ID: 23229472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.
    Wendorff M; Garcia Alvarez HM; Østerbye T; ElAbd H; Rosati E; Degenhardt F; Buus S; Franke A; Nielsen M
    Front Immunol; 2020; 11():1705. PubMed ID: 32903714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction.
    Nielsen M; Lund O
    BMC Bioinformatics; 2009 Sep; 10():296. PubMed ID: 19765293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles.
    Reynolds CJ; Jones C; Blohmke CJ; Darton TC; Goudet A; Sergeant R; Maillere B; Pollard AJ; Altmann DM; Boyton RJ
    Immunology; 2014 Nov; 143(3):438-46. PubMed ID: 24891088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
    Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
    Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction.
    Mei S; Li F; Leier A; Marquez-Lago TT; Giam K; Croft NP; Akutsu T; Smith AI; Li J; Rossjohn J; Purcell AW; Song J
    Brief Bioinform; 2020 Jul; 21(4):1119-1135. PubMed ID: 31204427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.
    van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
    Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.